TRIFLUCAN 40 mg/ml, powder for oral suspension bottle
Active ingredients: Fluconazole
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIFLUCAN 40 mg/ml, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) contenant 24,4 g de poudre avec seringue(s) pour administration orale graduée avec adaptateur(s) pour flacon
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64940811CIP74900563CIP133400949005635Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUCONAZOLEpoudre | 40 mg · 1 ml de suspension reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.